Personal information

Other IDs

Scopus Author ID: 6507113380
SciProfiles: 1248206
Loop profile: 196939

Keywords

Central Nervous System, Serotonin, Neuroinflammation, Molecular Imaging, Pharmacokinetics

Activities

Collapse all

Employment (2)

Università degli Studi di Bari Aldo Moro: Bari, Puglia, IT

2017-02-17 to present | Associate Professor (Dipartimento di Farmacia-Scienze del Farmaco)
Employment
Source: Self-asserted source
Enza Lacivita

Università degli Studi di Bari Aldo Moro: Bari, Puglia, IT

2005-02-01 to 2017-02-16 | Assistant Professor (Dipartimento di Farmacia-Scienze del Farmaco)
Employment
Source: Self-asserted source
Enza Lacivita

Education and qualifications (2)

Università degli Studi di Bari Aldo Moro: Bari, Puglia, IT

1997-11-01 to 2001-01-21 | PhD (Dipartimento Farmaco-Chimico)
Education
Source: Self-asserted source
Enza Lacivita

Università degli Studi di Bari Aldo Moro: Bari, Puglia, IT

1996-11-14 | Master degree in Chemistry and Pharmaceutical Technologies
Education
Source: Self-asserted source
Enza Lacivita

Professional activities (1)

Societa Chimica Italiana: Rome, Lazio, IT

2008-11-01 to present
Membership
Source: Self-asserted source
Enza Lacivita

Funding (7)

Developing 5-HT7 receptor inverse agonist drugs to tackle tau aggregation

2024-01 to 2026-12 | Grant
Alzheimer's Association (IL, IL, US)
Source: Self-asserted source
Enza Lacivita

Biased agonists for Formyl Peptide Receptor 2 (FPR2) as new anti-inflammatory and pro-resolving agents: an innovative approach for the treatment of chronic inflammatory diseases

2023-12 to 2025-11 | Grant
Ministero dell'Università e della Ricerca (Roma, IT)
GRANT_NUMBER:

P20227TATA
Source: Self-asserted source
Enza Lacivita

Identification of a molecular scaffold for the development of a PET tracer for purinergic P2X7 receptor for molecular imaging of neuroinflammation in PD

2023-03 to 2024-09 | Grant
Michael J. Fox Foundation (New York, US)
GRANT_NUMBER:

MJFF-022329
Source: Self-asserted source
Enza Lacivita

REWIND: Reverting stem cellular sEnescence With antiagIng Natural compounDs

2022-01 to 2024-01 | Grant
Universita degli Studi di Bari Aldo Moro (Bari, IT)
Source: Self-asserted source
Enza Lacivita

Promoting resolution of inflammation as an innovative therapeutic strategy for central nervous system disorders characterized by neuroinflammation

2022-01 to 2023-12 | Grant
Ministero degli Affari Esteri e della Cooperazione Internazionale (Roma, IT)
Source: Self-asserted source
Enza Lacivita

Drug development of pro-resolving ALX/FPR2 agonists for Alzheimer's Disease

2018-06 to 2020-06 | Grant
Alzheimer Association (Chicago, US)
Source: Self-asserted source
Enza Lacivita

Fondo di FInanaziamento della Ricerca di Base

2017-10 to present | Grant
Ministero dell’Istruzione, dell’Università e della Ricerca (Roma, IT)
Source: Self-asserted source
Enza Lacivita

Peer review (25 reviews for 9 publications/grants)

Review activity for ACS medicinal chemistry letters. (2)
Review activity for Analytical chemistry. (1)
Review activity for Bioorganic chemistry. (2)
Review activity for ChemMedChem. (1)
Review activity for European journal of medicinal chemistry. (4)
Review activity for Journal of medicinal chemistry. (11)
Review activity for Journal of neuroinflammation (1)
Review activity for Molecular medicine. (1)
Review activity for Pharmacological research. (2)
How many people are using ORCID?